In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs

Journal of Rheumatology

Volumn 24, Issue 8, 1997, Pages 1471-1476

  Seitz, Michael ^a   Loetscher, Pius ^a   Dewald, Beatrice ^b   Towbin, Harry ^c   Baggiolini, Marco ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CIBA GEIGY LTD   (Switzerland)

Author keywords

antirheumatic drugs; cytokine inhibitors; cytokines; PGE; rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHOTREXATE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SYNOVIOCYTE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FIBROBLASTS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKOCYTES, MONONUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIALOGLYCOPROTEINS; SYNOVIAL MEMBRANE;

EID: 0030795025     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lipsky PE, Davis LS, Cush JJ, Oppenheimer-Marks N: The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol 1989;11:123-62.
2. Dayer JM, Fenner H: The role of cytokines and their inhibitors in arthritis. Ballieres Clin Rheumatol 1992;6:455-516.
3. Firestein GS, Alvaro Gracia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
4. Wood NC, Symons JA, Dickens E, Duff GW: In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 1992;87:183-9.
5. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor alpha in synovial tissue and the cartilage pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
6. Koch Ä, Kunkel SL, Burrows JC, et al: Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
7. Roux-Lombard P, Modoux C, Vischer T, Grassi J, Dayer JM: Inhibitors of interleukin-1 activity in synovial fluids and in cultured synovial fluid mononuclear cells. J Rheumatol 1992;19:517-23.
8. Towbin H, Schmitz A, van Oostrum J, et al: Monoclonal antibody based enzyme-linked and chemiluminescent assay for the human interleukin-1 receptor antagonist. Application to measure hIL-1Ra levels in monocyte cultures and synovial fluids. J Immunol Methods 1994;170:125-35.
9. Roux-Lombard P, Punzi L, Hasler F, et al: Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993;36:485-9.
10. Miltenburg AMM, Aderka D, van Laar JM, et al: Levels of soluble receptors for tumor necrosis factor type I and type II in paired synovial fluids of arthritis patients. Rheumatol Int 1993;13:117-9.
11. Firestein GS, Boyle DL, Yu C, et al: Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
12. Klareskog L, Forsum U, Malmnas Tjernlund U, et al: Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue. Scand J Immunol 1981;14:183-92.
13. Seitz M, Loetscher P, Fey MF, Tobler A: Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid-arthritis and osteoarthritis patients. Br J Rheumatol 1994;33:613-9.
14. Heilig B, Wermann M, Gallati H, et al: Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Invest 1992;70:22-8.
15. Häupl T, Burmester GR, Hahn G, et al: Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: Inhibition of interleukin-1 release by the B95-8, but not the P3HR virus strain. Rheumatol Int 1989;9:153-60.
16. Bazzoni F, Cassatella MA, Rossi F, Ceska M, et al: Phagocytosing neutrophils produce and release high amounts of the neutrophilactivating peptide 1/interleukin-8. J Exp Med 1991;173:771-4.
17. Loetscher P, Deward B, Baggiolini M, Seitz M: Monocyte chemoattractant protein-1 and interleukin-8 production by rheumatoid synoviocytes. Effects of antirheumatic drugs. Cytokine 1994;6:162-70.
18. Seitz M, Deimann W, Gram N, Hunstein W, Gemsa D: Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol 1983;29:242-53.
19. Harris ED Jr: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-82.
20. Granelli-Piperno A, Nolan P, Inaba K, Steinmann RM: The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med 1990;172:1869-72.
21. Tobler A, Meier R, Seitz M, et al: Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992;79:45-51.
22. Allen JB, Wong HL, Costa GL, et al: Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 1993;151:4344-51.
23. Seitz M, Loetscher P, Dewald B, et al: Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995;25:1129-32.
24. Yanagawa H, Sone S, Haku T, et al: Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 1995;12:71-6.
25. Kremer JM, Galivan J, Streckfuss A, Kamen B: Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 1986;29:832-5.
26. Seitz M, Loetscher P, Dewald B, et al: Methotrexate action in rheumatoid arthritis stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 1995;34:602-9.
27. Seitz M, Loetscher P, Dewald B, et al: Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors. IL-1β, and IL-8-markers of remission in rheumatoid arthritis during treatment with methotrexate. J Rheumatol 1996;23:1512-6.
28. DiPadova FE: Pharmacology of cyclosporine (Sandimmune). V. Pharmacological effects on immune function: In vitro studies. Pharmacol Rev 1989;41:373-405.
29. McGuire MKB, Meats JE, Russell RGG: Cell-cell interactions in the rheumatoid joints. Agents Actions 1980;10:485-90.
30. Bomalaski JS, Williamson PK, Zurier RB: Prostaglandins and the inflammatory response. Clin Lab Med 1983;3:695-17.
31. Robinson DR, McGuire MB, Levine L: Prostaglandins in the rheumatic diseases. Ann NY Acad Sci 1974;256:318-29.
32. Bombardieri S, Cattani P, Ciabattoni G, et al: The synovial prostaglandin system in chronic inflammatory arthritis: Differential effects of steroidal and nonsteroidal antiinflammatory drugs. Br J Pharmacol 1981;73:893-901.
33. 2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 1977;6:151-4.
34. Robinson DR, Tashjian AH, Levine L: Prostaglandin stimulated bone resorption by rheumatoid synovia: A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-8.
35. Dayer JM, Krane SM, Russell RGG, et al: Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci USA 1976;73:945-9.
36. Salmon JA, Higgs GA, Vane JR, et al: Synthesis of arachidonate cyclooxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. Ann Rheum Dis 1983;42:36-9.